← Open Payments lookup

ABRAHAM KIMELI: Open Payments

NPI 1215404413 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,733 in 237 payments from 18 companies in 2025. Trend: 2023 $3,346 · 2024 $2,654 · 2025 $3,733

Food & beverage: $3,733
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.41$617
Alkermes, Inc.19$406
Vanda Pharmaceuticals Inc.27$367
Neurocrine BioSciences, Inc.22$341
Lundbeck LLC12$256
Janssen Pharmaceuticals, Inc13$248
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$214
Collegium Pharmaceutical, Inc.17$205
Axsome Therapeutics, Inc.9$194
E.R. Squibb & Sons, L.L.C.21$192

Products named: REXULTI, ARISTADA, INGREZZA, FANAPT, ABILIFY ASIMTUFII, CAPLYTA, Jornay PM, Auvelity.

Industry payments across MI — which companies pay providers there.